Telix Pharmaceuticals | TLX - Devedores Comerciais

Preço das Ações
12.75
Mudança Diária
0.34 2.74%
Mensal
32.67%
Anual
-54.43%
Q1 Previsão
12.48




Devedores Comerciais Alterar Data
Cochlear AUD 568.4M 17.5M 2025-12
CSL USD 4.32B 1.35B 2025-12
Integral Diagnostics AUD 24.82M 10.78M 2024-06
Mayne Pharma AUD 193.22M 5.64M 2024-06
Medical Developments International AUD 7.48M 174K 2025-12
Mesoblast USD 43.3M 28.43M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Pacific Edge NZD 3.75M 1.22M 2025-12
Paradigm Biopharmaceuticals AUD 6.31M 58.85K 2025-12
Polynovo AUD 24.21M 945K 2025-12
PYC Therapeutics AUD 32.59M 8.52M 2025-12
Ramsay Health Care AUD 2.48B 22.3M 2025-12
ResMed USD 1.05B 88.62M 2025-12
Sonic Healthcare AUD 1.39B 23.76M 2024-12